Core-shell Hybrid Liposomal Vesicles Loaded with Panax Notoginsenoside: Preparation, Characterization and Protective Effects on Global Cerebral Ischemia/reperfusion Injury and Acute Myocardial Ischemia in Rats

Overview

Journal Int J Nanomedicine

Publisher Dove Medical Press

Specialty Biotechnology

Date 2012 Aug 24

PMID 22915851

Citations 30

Authors

Jing Zhang

Xizhen Han

Xiang Li

Yun Luo

Haiping Zhao

Ming Yang

Bin Ni

Zhenggen Liao

Affiliations

Soon will be listed here.

Abstract

Purpose: Novel panax notoginsenoside-loaded core-shell hybrid liposomal vesicles (PNS-HLV) were developed to resolve the restricted bioavailability of PNS and to enhance its protective effects in vivo on oral administration.

Methods: Physicochemical characterizations of PNS-HLV included assessment of morphology, particle size and zeta potential, encapsulation efficiency (EE%), stability and in vitro release study. In addition, to evaluate its oral treatment potential, we compared the effect of PNS-HLV on global cerebral ischemia/reperfusion and acute myocardial ischemia injury with those of PNS solution, conventional PNS-loaded nanoparticles, and liposomes.

Results: In comparison with PNS solution, conventional PNS-loaded nanoparticles and liposomes, PNS-HLV was stable for at least 12 months at 4°C. Satisfactory improvements in the EE% of notoginsenoside R1, ginsenoside Rb1, and ginsenoside Rg1 were shown with the differences in EE% shortened and the greater controlled drug release profiles were exhibited from PNS-HLV. The improvements in the physicochemical properties of HLV contributed to the results that PNS-HLV was able to significantly inhibit the edema of brain and reduce the infarct volume, while it could markedly inhibit H(2)O(2), modified Dixon agar, and serum lactate dehydrogenase, and increase superoxide dismutase (P < 0.05).

Conclusion: The results of the present study imply that HLV has promising prospects for improving free drug bioactivity on oral administration.

Citing Articles

Nanomedicines as Guardians of the Heart: Unleashing the Power of Antioxidants to Alleviate Myocardial Ischemic Injury.

Han D, Wang F, Shen D Theranostics. 2024; 14(13):5336-5370.

PMID: 39267789 PMC: 11388064. DOI: 10.7150/thno.99961.

The Optimization Design of Macrophage Membrane Camouflaging Liposomes for Alleviating Ischemic Stroke Injury through Intranasal Delivery.

Liu T, Wang Y, Zhang M, Zhang J, Kang N, Zheng L Int J Mol Sci. 2024; 25(5).

PMID: 38474179 PMC: 10931763. DOI: 10.3390/ijms25052927.

A comprehensive review on Moringa oleifera nanoparticles: importance of polyphenols in nanoparticle synthesis, nanoparticle efficacy and their applications.

Perumalsamy H, Balusamy S, Sukweenadhi J, Nag S, MubarakAli D, Farh M J Nanobiotechnology. 2024; 22(1):71.

PMID: 38373982 PMC: 10877787. DOI: 10.1186/s12951-024-02332-8.

Self-Double-Emulsifying Drug Delivery System Enteric-Coated Capsules: A Novel Approach to Improve Oral Bioavailability and Anti-inflammatory Activity of Panax notoginseng Saponins.

Wang Y, Shang Y, Tang F, Qiu K, Wei X, Wang Z AAPS PharmSciTech. 2023; 24(4):90.

PMID: 36977927 DOI: 10.1208/s12249-023-02549-0.

Notoginsenoside R1-loaded mesoporous silica nanoparticles targeting the site of injury through inflammatory cells improves heart repair after myocardial infarction.

Li H, Zhu J, Xu Y, Mou F, Shan X, Wang Q Redox Biol. 2022; 54:102384.

PMID: 35777198 PMC: 9287735. DOI: 10.1016/j.redox.2022.102384.

References

Govender T, Riley T, Ehtezazi T, Garnett M, Stolnik S, Illum L . Defining the drug incorporation properties of PLA-PEG nanoparticles. Int J Pharm. 2000; 199(1):95-110. DOI: 10.1016/s0378-5173(00)00375-6. View

Siesjo B . Pathophysiology and treatment of focal cerebral ischemia. Part II: Mechanisms of damage and treatment. J Neurosurg. 1992; 77(3):337-54. DOI: 10.3171/jns.1992.77.3.0337. View

Takino Y, Odani T, Tanizawa H, Hayashi T . Studies on the absorption, distribution, excretion and metabolism of ginseng saponins. I. Quantitative analysis of ginsenoside Rg1 in rats. Chem Pharm Bull (Tokyo). 1982; 30(6):2196-201. DOI: 10.1248/cpb.30.2196. View

Sun K, Wang C, Guo J, Horie Y, Fang S, Wang F . Protective effects of ginsenoside Rb1, ginsenoside Rg1, and notoginsenoside R1 on lipopolysaccharide-induced microcirculatory disturbance in rat mesentery. Life Sci. 2007; 81(6):509-18. DOI: 10.1016/j.lfs.2007.06.008. View

Karikura M, Miyase T, Tanizawa H, Taniyama T, Takino Y . Studies on absorption, distribution, excretion and metabolism of ginseng saponins. VII. Comparison of the decomposition modes of ginsenoside-Rb1 and -Rb2 in the digestive tract of rats. Chem Pharm Bull (Tokyo). 1991; 39(9):2357-61. DOI: 10.1248/cpb.39.2357. View

Avgoustakis K, Beletsi A, Panagi Z, Klepetsanis P, Livaniou E, Evangelatos G . Effect of copolymer composition on the physicochemical characteristics, in vitro stability, and biodistribution of PLGA-mPEG nanoparticles. Int J Pharm. 2003; 259(1-2):115-27. DOI: 10.1016/s0378-5173(03)00224-2. View

Chen X, Zhu Y, Zhu L, Huang C, Chen Y, Chen L . Ginsenoside Rg1 attenuates dopamine-induced apoptosis in PC12 cells by suppressing oxidative stress. Eur J Pharmacol. 2003; 473(1):1-7. DOI: 10.1016/s0014-2999(03)01945-9. View

Xiong J, Guo J, Huang L, Meng B, Ping Q . Self-micelle formation and the incorporation of lipid in the formulation affect the intestinal absorption of Panax notoginseng. Int J Pharm. 2008; 360(1-2):191-6. DOI: 10.1016/j.ijpharm.2008.04.016. View

Lee J, Lee E, Kim D, Lee J, Yoo J, Koh B . Studies on absorption, distribution and metabolism of ginseng in humans after oral administration. J Ethnopharmacol. 2009; 122(1):143-8. DOI: 10.1016/j.jep.2008.12.012. View

10.

Odani T, Tanizawa H, Takino Y . Studies on the absorption, distribution, excretion and metabolism of ginseng saponins. II. The absorption, distribution and excretion of ginsenoside Rg1 in the rat. Chem Pharm Bull (Tokyo). 1983; 31(1):292-8. DOI: 10.1248/cpb.31.292. View

11.

Zhang J, Guan P, Wang T, Chang D, Jiang T, Wang S . Freeze-dried liposomes as potential carriers for ocular administration of cytochrome c against selenite cataract formation. J Pharm Pharmacol. 2009; 61(9):1171-8. DOI: 10.1211/jpp/61.09.0006. View

12.

Cascone M, Lazzeri L, Carmignani C, Zhu Z . Gelatin nanoparticles produced by a simple W/O emulsion as delivery system for methotrexate. J Mater Sci Mater Med. 2004; 13(5):523-6. DOI: 10.1023/a:1014791327253. View

13.

Lee C, Lee H, Lee K . O-palmitoylcurdlan sulfate (OPCurS)-coated liposomes for oral drug delivery. J Biosci Bioeng. 2005; 100(3):255-9. DOI: 10.1263/jbb.100.255. View

14.

Luo F, Wang S, Qi L, Song J, Lv T, Bai J . Protective effect of panaxatriol saponins extracted from Panax notoginseng against MPTP-induced neurotoxicity in vivo. J Ethnopharmacol. 2010; 133(2):448-53. DOI: 10.1016/j.jep.2010.10.017. View

15.

Haidar Z, Hamdy R, Tabrizian M . Protein release kinetics for core-shell hybrid nanoparticles based on the layer-by-layer assembly of alginate and chitosan on liposomes. Biomaterials. 2007; 29(9):1207-15. DOI: 10.1016/j.biomaterials.2007.11.012. View

16.

Peng X, Dai L, Huang C, He C, Yang B, Chen L . Relationship between anti-fibrotic effect of Panax notoginseng saponins and serum cytokines in rat hepatic fibrosis. Biochem Biophys Res Commun. 2009; 388(1):31-4. DOI: 10.1016/j.bbrc.2009.07.099. View

17.

Panyam J, Labhasetwar V . Sustained cytoplasmic delivery of drugs with intracellular receptors using biodegradable nanoparticles. Mol Pharm. 2005; 1(1):77-84. DOI: 10.1021/mp034002c. View

18.

Cicero A, Bandieri E, Arletti R . Orally administered Panax notoginseng influence on rat spontaneous behaviour. J Ethnopharmacol. 2000; 73(3):387-91. DOI: 10.1016/s0378-8741(00)00277-4. View

19.

Cicero A, Vitale G, Savino G, Arletti R . Panax notoginseng (Burk.) effects on fibrinogen and lipid plasma level in rats fed on a high-fat diet. Phytother Res. 2003; 17(2):174-8. DOI: 10.1002/ptr.1262. View

20.

Lei X, Chiou G . Cardiovascular pharmacology of Panax notoginseng (Burk) F.H. Chen and Salvia miltiorrhiza. Am J Chin Med. 1986; 14(3-4):145-52. DOI: 10.1142/S0192415X86000235. View